Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Y. M. Pozdnyakov"'
Autor:
I. N. Grigorieva, Y. M. Pozdnyakov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 5, Iss 6, Pp 51-54 (2016)
Results of combined therapy of gallstone disease (GSD), non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH) and hypercholesterolemia (HCE) with statins and ursodeoxycholic acid (UDCA) are analyzed. In GSD statin therapy wa
Externí odkaz:
https://doaj.org/article/0defd67051ff4d2683d99a106c112162
Autor:
N Pogosova, S A Boytsov, A K Ausheva, O Y Sokolova, A O Salbieva, A V Karpova, A I Yusubova, Y M Pozdnyakov
Publikováno v:
European Heart Journal. 42
Background Regular monitoring of risk factors control in patients (pts) with atherosclerotic cardiovascular diseases is of paramount importance for interventions and policies targeting secondary prevention settings. Purpose To describe traditional ri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb382c1874a160c9d4661ef010ba3a0a
https://doi.org/10.1093/eurheartj/ehab724.2539
https://doi.org/10.1093/eurheartj/ehab724.2539
Autor:
N Pogosova, S A Boytsov, A K Ausheva, O Y Sokolova, Y M Pozdnyakov, A O Salbieva, A V Karpova, A I Yusubova, A A Arutyunov
Publikováno v:
European Heart Journal. 42
Background Several drug classes have shown their ability to improve risk factors control and prognosis in coronary heart disease (CHD). Therefore, it is important to monitor the prescription patterns on a regular basis to ensure that all the eligible
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8ba5386673c495a98f2ac1b28f0f141
https://doi.org/10.1093/eurheartj/ehab724.2554
https://doi.org/10.1093/eurheartj/ehab724.2554
Autor:
Y M Pozdnyakov, Rafael G. Oganov, N V Pogosova, A I Yusubova, Y V Loshkarev, A O Salbieva, A K Ausheva, V G Vinokurov, O Y Sokolova, N V Gomyranova, A V Karpova, T A Gusarova, I N Lel'chuk, Sergey Boytsov, S S Isakova, S N Strelkova, A A Kursakov, A O Klimova, A M Allenov, R V Rubanov
Publikováno v:
Scopus-Elsevier
Background. The picture of primary prevention obtained from real-life practice makes possible scheduling measures for prevention improvement. Aim. To analyze features of drug and non-drug therapy aimed at decreasing cardiovascular risk in Russian pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c82b7ed01f713203b24d7cff9069d49
https://doi.org/10.18087/cardio.2412
https://doi.org/10.18087/cardio.2412
Autor:
V G Vinokurov, A V Karpova, O Y Sokolova, I N Lel'chuk, R V Rubanov, A K Ausheva, Y V Loshkarev, A O Salbieva, N V Pogosova, A M Allenov, A A Kursakov, Y M Pozdnyakov, A I Yusubova, N V Gomyranova, Rafael G. Oganov, Sergey Boytsov, A O Klimova, S S Isakova, S N Strelkova
Publikováno v:
Scopus-Elsevier
Relevance. Evaluation of the effectiveness of risk management in persons with high cardiovascular risk is an important element in reducing the death rate of the population from cardiovascular diseases (CVD). Aim. Analysis of the prevalence and level
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf53eebf2070faa19c2b12593f17094b
https://doi.org/10.18087/cardio.2411
https://doi.org/10.18087/cardio.2411
Autor:
Nana Pogosova, Sergey Boytsov, A O Salbieva, O Y Sokolova, A I Yusubova, S.A. Isakova, A K Ausheva, Y M Pozdnyakov, Rafael G. Oganov, A.A. Kursakov
Publikováno v:
European Heart Journal. 38
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6cc08f6053628a091da8c64b29149cb8
https://doi.org/10.1093/eurheartj/ehx504.p4558
https://doi.org/10.1093/eurheartj/ehx504.p4558
Autor:
K K Bedeynikova, E B Akhmedova, Mn V Gomyranova, O J Sokolova, Sergey Boytsov, M N Kovrigina, T A Gusarova, N A Yeliseeva, A K Ausheva, A A Kursakov, N V Pogosova, Rafael G. Oganov, Ma O Salbieva, N A Skazin, Y M Pozdnyakov, I N Lel'chuk
Publikováno v:
Kardiologiia. 55(12)
The results of the Russian part of the EUROASPIRE IV study show that we have a large room for improvement of traditional risk factors management in CAD patients hospitalized for acute myocardial infarction, acute coronary syndromes, PCI or CABG (at a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bee7697056bc3ed1ff9daefc7fb927c
https://pubmed.ncbi.nlm.nih.gov/28294772
https://pubmed.ncbi.nlm.nih.gov/28294772
Autor:
Y. M. Pozdnyakov, I. N. Grigorieva
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 5, Iss 6, Pp 51-54 (2016)
Results of combined therapy of gallstone disease (GSD), non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH) and hypercholesterolemia (HCE) with statins and ursodeoxycholic acid (UDCA) are analyzed. In GSD statin therapy wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc1f6539cbd5ef755fcadf712e9db7e2
https://doi.org/10.20996/1819-6446-2009-5-6-51-54
https://doi.org/10.20996/1819-6446-2009-5-6-51-54